dc.contributor.author | Guney, A.I. | |
dc.contributor.author | Ergec, D.S. | |
dc.contributor.author | Tavukcu, H.H. | |
dc.contributor.author | Koc, G. | |
dc.contributor.author | Kirac, D. | |
dc.contributor.author | Ulucan, K. | |
dc.contributor.author | Javadova, D. | |
dc.contributor.author | Turkeri, L. | |
dc.date.accessioned | 2021-12-21T08:41:56Z | |
dc.date.available | 2021-12-21T08:41:56Z | |
dc.date.issued | 2012 | |
dc.identifier.issn | 19450265 | |
dc.identifier.uri | https://doi.org/10.1089/gtmb.2011.0227 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1553 | |
dc.description.abstract | Background: Mitochondrial DNA (mtDNA) mutations have been recently described in various tumors; however, data focusing on bladder cancer are scarce. To understand the significance of mtDNA mutations in bladder cancer development, we investigated the mtDNA | |
dc.language.iso | English | |
dc.title | Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer | |
dc.type | Article | |
dc.relation.journal | Genetic Testing and Molecular Biomarkers | |
dc.identifier.issue | 7 | |
dc.identifier.startpage | 672 | |
dc.identifier.endpage | 678 | |
dc.identifier.volume | 16 | |
dc.identifier.doi | 10.1089/gtmb.2011.0227 | |
dc.relation.issue | 7 | |
dc.relation.volume | 16 | |